Abstract
A 65-year-old man with coronavirus disease 2019 (COVID-19) was admitted to our hospital. Computed tomography detected bilateral pneumonia with a lung nodule suspicious for lung cancer. Lobectomy was performed 3 months after the treatment for COVID-19 without any complications. The surgical specimen revealed fibrosis below the pleura with a small collection of lymphocytes and intravascular hemorrhagic thrombosis, and no residual RNA was detected. This is the first report describing a surgical specimen after recovery from COVID-19 pneumonia, and suggests that elective thoracic surgery can be performed safely, depending on the patient’s respiratory function, without infectious risk.
Keywords: COVID-19; Lung cancer; SARS-CoV-2.
【저자키워드】 COVID-19, SARS-CoV-2, lung cancer, 【초록키워드】 coronavirus disease, SARS-CoV-2, Coronavirus disease 2019, COVID-19 pneumonia, Lymphocytes, thrombosis, Pneumonia, Respiratory function, hospital, lung, fibrosis, tomography, surgical, lung cancer, RNA, Computed tomography, lymphocyte, complications, Thoracic Surgery, Thoracic, Hemorrhagic, Lobectomy, Lung Nodule, specimen, bilateral pneumonia, pleura, infectious risk, performed, the patient, was performed, treatment for COVID-19, 【제목키워드】 Pneumonia, lung, Elective, treatment for COVID-19,